| Period Ending | 31-Dec-2011 | 31-Dec-2010 | 31-Dec-2009 | 31-Dec-2008 |
|---|
|
Total Revenue
|
36,286,000
|
29,201,000
|
24,909,000
|
24,670,000
| | Cost of Revenue | 21,359,000 | 15,958,000 | 12,437,000 | 12,627,000 | | |
Gross Profit
|
14,927,000
|
13,243,000
|
12,472,000
|
12,043,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative |
-
|
-
|
-
|
-
|
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses | 27,782,000 | 22,080,000 | 17,456,000 | 17,548,000 | | | |
Operating Income or Loss
|
8,504,000
|
7,121,000
|
7,453,000
|
7,122,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
-
|
-
|
-
|
|
Earnings Before Interest And Taxes | 8,504,000 | 7,121,000 | 7,453,000 | 7,122,000 |
|
Interest Expense | (1,375,000) | (1,369,000) | (1,118,000) | (1,066,000) |
|
Income Before Tax |
-
|
-
|
-
|
-
|
|
Income Tax Expense | 1,630,000 | 1,638,000 | 1,453,000 | 47,000 |
|
Minority Interest | (345,000) | (637,000) | (248,000) | (373,000) |
|
|
|
Net Income From Continuing Ops | 32,555,000 | 38,889,000 | 22,141,000 | 6,226,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
32,210,000
|
38,252,000
|
21,893,000
|
5,853,000
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
-
|
-
|
-
|
-
|
|